Stock screener

HRMY

Conviction 92HealthcareScan · Thu, Sep 24, 2026

Harmony Biosciences Holdings, Inc. (HRMY) closed at $41.19 (+1.75%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 88, -3.9% from its 52-week high, +10.2% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

HRMY$41.19+1.75%
ResistanceSupportVol 14Insider sell
63 bars
3
Vol MA14 1.33M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Harmony Biosciences Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.harmonybiosciences.com ↗
Price41.19
Change+1.75%
Gap-0.40%
Rel volume2.21×
Avg volume1.17M
Avg $ vol48.86M
SMA 2041.45
SMA 5038.93
SMA 20034.62
Price vs 50+5.82%
Price vs 200+18.96%
MA stackbullish
50/200 cross—
Supertrendup · 39.06
RSI (14)53
MACD hist-0.26
MACD crossbear · 4d
Stoch %K / %D41 / 29
ADX (14)37
+DI / −DI21 / 18
RSI divergence—
MACD divergence—
ATR %3.20%
ADR %3.03%
52w high42.86
52w low25.90
From 52w high-3.90%
Above 52w low+59.03%
New 52w highNo
SqueezeOff
Bollinger width9.58%
%B0.43
Donchian pos49.12%
Donchian high43.49
Donchian low38.97
AVWAP (52w high)41.88
vs AVWAP high-1.64%
AVWAP (52w low)34.14
vs AVWAP low+20.64%
OBV trendFlat
Chaikin MF (20)-0.13
Today vs 20d2.21×
Avg vol (14d)1.33M
Avg vol (20d)1.17M
Avg $ vol (20d)48.86M
Market cap2.4B
RS Rating88 / 99
RS 3m (vs SPY)+16.19%
RS 6m (vs SPY)+32.48%
RS line new highNo
Trend template6/8
Technical rank86.8
1 week-3.63%
1 month+5.75%
3 months+20.69%
6 months+49.29%
1 year+28.44%
YTD+10.19%
P/E15.12
P/B2.40
P/S2.76
P/FCF6.90
EPS2.71
Div yield—
ROE15.88%
ROA11.56%
Debt/Eq0.15
Current3.48
EV/EBITDA—
Gross margin77.16%
Net margin18.27%
Rev growth21.51%
EPS growth9.07%
Price target43.67
Target upside6.02%
Analyst ratingBuy
Institutional101.87%
Ent. value2B
Revenue261.28M
Net income75.43M
Gross profit198.08M
Free cash flow347.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57.89M
Employees293
ListedWed, Aug 19, 2020
Free float47.26M
Float %82.1%
Short interest5.16M
Days to cover9.1d
Short volume72.0%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.28 vs $0.97
Last surprise+32.0% beat
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank86.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance43.38
Support36.00
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 19 – Aug 31
    9 scans
  2. Breaking out now
    Sep 1
    1 scan
  3. Setting up
    Sep 16 – Sep 21
    4 scans

Recent news

Congress activity

Disclosed STOCK Act trades in HRMY

All disclosures →
No recent disclosed trades by Congress in HRMY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HRMY · open-market 4 sells

InsiderSideShares
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-09-08
Sell4.5K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-09-08
Sell1K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-09-08
Exercise12.2K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-09-08
Exercise10.75K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-09-08
Sell22.95K
Budur Kumar
CHIEF MEDICAL OFFICER · Stock Option · 2026-09-08
Exercise12.2K
Budur Kumar
CHIEF MEDICAL OFFICER · Stock Option · 2026-09-08
Exercise10.75K
Budur Kumar
CHIEF MEDICAL OFFICER · Common Stock · 2026-09-04
Sell5.5K
Graf R. Mark
Director · Stock Option · 2026-05-14
Grant21.87K
Sabater Juan A.
Director · Stock Option · 2026-05-14
Grant21.87K

SEC filings

EDGAR filings in HRMY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.